Suppr超能文献

给药途径调节晚期黑色素瘤患者树突状细胞疫苗诱导的抗原特异性 T 细胞的产生。

Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.

机构信息

Department of Medical Oncology,Nijmegen Centre for Molecular Life Sciences, and Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

出版信息

Clin Cancer Res. 2011 Sep 1;17(17):5725-35. doi: 10.1158/1078-0432.CCR-11-1261. Epub 2011 Jul 19.

Abstract

PURPOSE

It is unknown whether the route of administration influences dendritic cell (DC)-based immunotherapy. We compared the effect of intradermal versus intranodal administration of a DC vaccine on induction of immunologic responses in melanoma patients and examined whether concomitant administration of interleukin (IL)-2 increases the efficacy of the DC vaccine.

EXPERIMENTAL DESIGN

HLA-A2.1(+) melanoma patients scheduled for regional lymph node dissection were vaccinated four times biweekly via intradermal or intranodal injection with 12 × 10⁶ to 17 × 10⁶ mature DCs loaded with tyrosinase and gp100 peptides together with keyhole limpet hemocyanin (KLH). Half of the patients also received low-dose IL-2 (9 MIU daily for 7 days starting 3 days after each vaccination). KLH-specific B- and T-cell responses were monitored in blood. gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFNγ release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.

RESULTS

In 19 of 43 vaccinated patients, functional tumor antigen-specific T cells could be detected. Although significantly more DCs migrated to adjacent lymph nodes upon intranodal vaccination, this was also highly variable with a complete absence of migration in 7 of 24 intranodally vaccinated patients. Intradermal vaccinations proved superior in inducing functional tumor antigen-specific T cells. Coadministration of IL-2 did not further augment the antigen-specific T-cell response but did result in higher regulatory T-cell frequencies.

CONCLUSION

Intradermal vaccination resulted in superior antitumor T-cell induction when compared with intranodal vaccination. No advantage of additional IL-2 treatment could be shown.

摘要

目的

目前尚不清楚给药途径是否会影响树突状细胞(DC)为基础的免疫治疗。我们比较了皮内和皮内注射 DC 疫苗对黑素瘤患者诱导免疫反应的效果,并研究了同时给予白细胞介素(IL)-2 是否会增加 DC 疫苗的疗效。

实验设计

计划进行区域淋巴结清扫的 HLA-A2.1(+)黑素瘤患者通过皮内或皮内注射,每两周接受一次 12×10⁶ 至 17×10⁶ 负载酪氨酸酶和 gp100 肽以及钥孔血蓝蛋白(KLH)的成熟 DC 疫苗,共进行四次。一半患者还接受低剂量 IL-2(9 MIU 每日,在每次接种后第 3 天开始连续 7 天)治疗。在血液中监测 KLH 特异性 B 细胞和 T 细胞反应。通过四聚体分析监测血液中的 gp100 和酪氨酸酶特异性 T 细胞反应,并通过延迟型超敏反应(DTH)皮肤试验活检中的四聚体和功能分析(用 51Cr 释放测定或 IFNγ 释放)监测,方法是用肽脉冲 T2 细胞或 gp100 或酪氨酸酶表达肿瘤细胞进行共培养。

结果

在 43 名接种疫苗的患者中,有 19 名检测到功能性肿瘤抗原特异性 T 细胞。虽然皮内接种疫苗时明显有更多的 DC 迁移到相邻淋巴结,但在 24 名皮内接种疫苗的患者中,有 7 名完全没有迁移,这种情况也高度可变。皮内接种疫苗在诱导功能性肿瘤抗原特异性 T 细胞方面效果更好。同时给予 IL-2 并不能进一步增强抗原特异性 T 细胞反应,但确实导致调节性 T 细胞频率升高。

结论

与皮内接种疫苗相比,皮内接种疫苗可诱导更好的抗肿瘤 T 细胞。同时给予 IL-2 治疗没有显示出优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验